Sunshine Guojian Pharmaceutical (688336.SH) has announced a forecasted net profit of 700 million to 772 million yuan, an increase of 137.73% to 162% compared to the previous year.
San Sheng Guojian (688336.SH) released the annual performance forecast for 2024, with the company expected to achieve...
Sunshine Guojian Pharmaceutical (688336.SH) released its annual performance forecast for 2024, with an estimated net profit attributable to the company's owners of 7 billion to 7.72 billion yuan, an increase of 137.73% to 162.00% year-on-year; it is expected to achieve a net profit attributable to the company's owners after deducting non-recurring gains and losses of 2.39 billion to 2.79 billion yuan, an increase of 15.57% to 34.83% year-on-year.
Related Articles

MS CONCEPT (08447) announces interim results, with a net loss of HK$1.521 million.

Zijin Mining Group (02899) plans to repurchase RMB2 billion to RMB3 billion of its A-shares.

US Stock Market Move | NVIDIA Corporation (NVDA.US) rose 4%; institutions believe the stock price has already priced in the risk of leadership changes.
MS CONCEPT (08447) announces interim results, with a net loss of HK$1.521 million.

Zijin Mining Group (02899) plans to repurchase RMB2 billion to RMB3 billion of its A-shares.

US Stock Market Move | NVIDIA Corporation (NVDA.US) rose 4%; institutions believe the stock price has already priced in the risk of leadership changes.






